🇺🇸 FDA
Patent

US 10584161

Monoclonal antibodies specific for heartland virus and methods of their use

granted A61KA61K2039/505A61K39/12

Quick answer

US patent 10584161 (Monoclonal antibodies specific for heartland virus and methods of their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61K39/12